# A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer

> **NCT00220051** · PHASE2 · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 109 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Oxaliplatin, Capecitabine
- **PROCEDURE:** Pre operative radiotherapy
- **PROCEDURE:** Surgical Resection

## Key facts

- **NCT ID:** NCT00220051
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2013-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220051, "A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00220051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*